Antiretroviral Therapy Journal Articles

• HIV-1 Group P Infection: Towards a Dead-End Infection? HIV-1 group P infections are extremely rare, but could they evolve towards a dead-end infection?
  AIDS, July 2018
• Ledipasvir/sofosbuvir +/- RBV Retreatment in HCV Patients Is ledipasvir/sofosbuvir with or without ribavirin a viable option for treating patients with HCV genotype 1 for whom treatment with simeprevir/sofosbuvir had previously failed?
  Alimentary Pharmacology & Therapeutics, June 2018
• Impact of Aging and HIV on Serologic Response to Flu Vaccine In what ways might patient age and HIV status impact seasonal influenza vaccine responses?
  AIDS, June 2018
• Twenty-Five Years of Lamivudine After 25 years, lamivudine continues to be recommended as part of ART regimens for HIV.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, June 2018
• HIV Preexposure Prophylaxis in the U.S. Military Services How well informed are US military health care providers regarding the use of HIV PrEP? Are at-risk military personnel being adequately counseled and treated?
  Morbidity & Mortality Weekly Report, June 2018
• A Multimedia Campaign Promoting HIV Testing Among MSM Did exposure to a new multimedia campaign result in an uptake of HIV testing rates among men who have sex with men?
  HIV Medicine, June 2018
• Neglect of Attention to Reproductive Health in HIV+ Women Are the contraceptive needs of women living with HIV being met? If not, why?
  HIV Medicine, May 2018
• Estimating HCV Prognosis Using Transient Elastography Is non-invasive transient elastography as accurate as histologic assessment of fibrosis progression rates in estimating prognosis in treatment-naive chronic hepatitis C patients?
  Journal of Viral Hepatitis, May 2018
• The Global Incidence of Kaposi's Sarcoma in the HIV/AIDS Era A new review provides insight into the global incidence of Kaposi's sarcoma among HIV-infected individuals.
  HIV Medicine, May 2018
• Effectiveness of Boosted Protease Inhibitor-Based ART What do the current data tell us about the long-term response to ART regimens containing protease inhibitors?
  HIV Medicine, May 2018
• Adverse Reactions to Integrase Strand Transfer Inhibitors Integrase strand transfer inhibitors are widely used in HIV infected patients, but what do we currently know about the adverse reactions associated with these antiretroviral drugs?
  AIDS, May 2018
• Mobile Health Intervention to Reduce HIV Transmission Read about a new mobile health behavioral intervention to promote HIV medication adherence -- which may help to achieve reductions in HIV transmission.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, May 2018
• High-Dose Corticosteroid Treatment and Mortality in ARDS Past studies have shown that high-dose corticosteroid therapy did not improve the outcomes of patients with ARDS -- but is it time to revisit the issue?
  BMC Pulmonary Medicine, May 2018
• National Audit of Perinatal HIV Infections in the UK A better understanding of the transmission of HIV from mother to baby could have important implications for prevention, engagement, and ART adherence.
  HIV Medicine, May 2018
• HIV Prevalence Among First-Presentation Psychotic Patients How often is first-episode psychosis associated with an HIV-related condition?
  HIV Medicine, May 2018
• Long-term Safety of Oral Anti-virals for Chronic HBV What does the latest evidence tell us about the long-term safety profiles of nucleoside analogues for chronic hepatitis B?
  Alimentary Pharmacology & Therapeutics, May 2018
• HIV and HPV, Precancerous Lesions, and Cervical Cancer Risks Find out about the role HIV infection may play in HPV acquisition and the risk for developing cervical cancer.
  AIDS, April 2018
• Chemsex and High-Risk Sexual Behaviours in HIV-Positive MSM Might sexualized drug use contribute to riskier sexual behaviors among men who have sex with men?
  HIV Medicine, April 2018
• OBV/PTV/r+DSV+RBV in Patients With HCV Cirrhosis Does real-life data confirm the results of clinical trials regarding the efficacy and safety profile of this DAA regimen in patients with HCV infection and cirrhosis?
  Liver International, April 2018
• PrEP Among MSM and the Transgender Population How willing are MSM and transgender individuals to use PrEP -- and how might its use impact sexual behavior among these populations? A new survey provides insight.
  HIV Medicine, April 2018